期刊
CURRENT PROBLEMS IN CANCER
卷 42, 期 1, 页码 40-48出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.currproblcancer.2017.10.007
关键词
Hepatocellular carcinoma; Immunotherapy; Drug development; Management; Review
类别
Hepatocellular carcinoma is a common malignancy which usually emerges on a background of chronic liver disease. Unfortunately, with contemporary management, patients with advanced hepatocellular carcinoma have few treatment options, and prognosis is poor. The emergence of immunotherapy has afforded new therapeutic opportunities. This article reviews the clinical evidence for immunotherapy in advanced hepatocellular carcinoma and presents ideas for future drug development. (C) 2018 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据